Urology · Dearborn, MI
NPI
1073741187
Since 2009
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
18100 Oakwood Blvd Ste 315
Dearborn, MI, 48124
Phone (313) 271-0066
Groups this clinician bills Medicare through
Medicare paid, 2024
$234K
13,282 services
Medicare patients, 2024
530
Average age 74
Drug cost, 2024
$770K
3,190 prescriptions
Company payments, 2025
$1,526
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jaclyn Milose was code J0585 (injection, onabotulinumtoxina, 1 unit), 7,700 times for 32 patients. In total Jaclyn Milose billed 13,282 services in 78 codes, and Medicare paid $234K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 7,700 | 32 | $4.85 | $37K |
| 81003 Clinical Chemistry | Office | 746 | 389 | $2.17 | $1,619 |
| 51798 Ultrasound - Nonspecific | Office | 523 | 339 | $8.51 | $4,450 |
| 99214 Office E&M - Established | Office | 419 | 281 | $93.30 | $39K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 173 | 30 | $50.60 | $8,754 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 150 | 124 | $12.45 | $1,868 |
| 99204 Office E&M - New | Office | 108 | 108 | $122.51 | $13K |
| 52000 Cystourethroscopy | Office | 108 | 96 | $182.71 | $20K |
| 99213 Office E&M - Established | Office | 90 | 79 | $68.83 | $6,195 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 78 | 25 | $39.48 | $3,079 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 75 | 42 | $39.85 | $2,989 |
| 96372 Injection Administration | Office | 53 | 12 | $10.34 | $548 |
| 52287 Cystourethroscopy | Office | 48 | 32 | $297.76 | $14K |
| 99459 Office/Outpatient Services | Office | 44 | 44 | $18.06 | $794 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 32 | 18 | $16.28 | $521 |
By year: 2022 $220K for 8,972 services; 2023 $221K for 11,542 services; 2024 $234K for 13,282 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 746 | 389 | $2.17 | $1,619 |
Medicare prescription drug claims, 2024
In 2024, the drug Jaclyn Milose prescribed most often to Medicare patients was Estradiol, with 692 prescriptions and refills. In total Jaclyn Milose wrote 3,190 Medicare prescriptions that cost $770K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 692 | 1,258 | 295 | $45K |
| Myrbetriq Mirabegron | 443 | 769 | 152 | $335K |
| Gemtesa Vibegron | 250 | 459 | 87 | $212K |
| Tamsulosin Hcl Generic | 196 | 480 | 66 | $3,752 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 176 | 339 | 104 | $6,251 |
| Cephalexin Generic | 168 | 172 | 123 | $594 |
| Methenamine Hippurate Generic | 161 | 326 | 49 | $14K |
| Mirabegron Er Mirabegron | 145 | 291 | 65 | $97K |
| Hydroxyzine Hcl Generic | 142 | 249 | 47 | $1,083 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 127 | 131 | 102 | $843 |
| Solifenacin Succinate Generic | 91 | 144 | 31 | $3,973 |
| Ciprofloxacin Hcl Generic | 78 | 78 | 57 | $217 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 62 | 152 | 17 | $6,906 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 57 | 134 | 21 | $1,066 |
| Trimethoprim Generic | 43 | 111 | 24 | $3,524 |
Brand drugs: 811 claims; generic drugs: 2,366 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jaclyn Milose $1,526 ($1,526 in general payments such as food, travel and fees) from 14 companies. The largest payer was Sumitomo Pharma America, Inc. with $357.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.